Beyond this background, MIF seems to be a good candidate marker to be evaluated in HFpEF since it was shown to be a marker for oxidative stress, organ fibrosis, cell damage, atherosclerosis, lung disease, rheumatic diseases, sepsis [21], severe illness, and chronic kidney disease [12, 13, 18, 19, 22–25]. This evidence concerns the gene MIF and lung disorder.